/
LTRN
$2.52-$0.03 (-1.13%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$33.9M
13M shares
52-week range
$1.11 – $4.75
39% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Change$-9.34
Lantern Pharma Inc. Common Stock
Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.
www.lanternpharma.com- Employees
- 16
- IPO / List date
- Jun 11, 2020
- HQ
- DALLAS, TX
Held by traders on TradeandTell
No one on the platform currently holds LTRN.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 116,000 | $158.9K |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded LTRN yet.
